Disc Medicine, Inc. faced a 22% stock price drop after the FDA issued a Complete Response Letter rejecting its new drug application for bitopertin due to uncertainties requiring more evidence. The Rosen Law Firm is investigating potential securities claims and preparing a class action lawsuit on behalf of shareholders who suffered losses from this event. Investors who purchased Disc Medicine securities may be eligible for compensation without upfront fees through a contingency fee arrangement. The law firm encourages affected investors to contact them for more information and to join the class action.
An attacker exploited a flaw in the third-party SquidRouterModule to drain $3.2 million from 86 Gnosis Safe wallets on Ethereum and Base within two hours. The vulnerability involved improper identity validation, allowing the attacker to impersonate a...
A pseudonymous US man filed a lawsuit in New York seeking ownership of over 39,000 dormant Bitcoin addresses estimated to hold about 3.7 million BTC worth $285 billion. The suit claims these wallets are abandoned property under New York's lost-proper...
Polygon co-founder Sandeep Nailwal announced the launch of Open Money Stack, a new blockchain platform aimed at neobanks and fintech firms. This platform provides an integrated API covering wallets, payments, and compliance, simplifying financial ser...
Ark Invest's Cathie Wood forecasts Bitcoin's price reaching between $710,000 and $762,000 in a base case, with a bull case up to $1.5 million by 2030. This projection is based on Bitcoin's market cap potentially hitting $16 trillion, fueled by increa...
Bitcoin's market structure is weakening due to declining institutional demand and fragile retail optimism. Spot Bitcoin ETF outflows exceeded $1.74 billion, and Binance saw a 425% surge in BTC inflows, signaling cautious holder behavior amid geopolit...
